Reference
Misch M, et al. D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma. Anticancer Research 33: 2093-2098, No. 5, May 2013. Available from: URL: http://ar.iiarjournals.org/content/33/5/2093.full - Germany
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1461, 11 (2013). https://doi.org/10.1007/s40278-013-4557-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-4557-9